93 related articles for article (PubMed ID: 19020734)
21. Inhibition of angiogenic initiation and disruption of newly established human vascular networks by juice from Morinda citrifolia (noni).
Hornick CA; Myers A; Sadowska-Krowicka H; Anthony CT; Woltering EA
Angiogenesis; 2003; 6(2):143-9. PubMed ID: 14739620
[TBL] [Abstract][Full Text] [Related]
22. Noni (Morinda citrifolia).
J Soc Integr Oncol; 2006; 4(4):199-200. PubMed ID: 17022928
[No Abstract] [Full Text] [Related]
23. Morinda citrifolia Linn (Noni): in vivo and in vitro reproductive toxicology.
Müller JC; Botelho GG; Bufalo AC; Boareto AC; Rattmann YD; Martins ES; Cabrini DA; Otuki MF; Dalsenter PR
J Ethnopharmacol; 2009 Jan; 121(2):229-33. PubMed ID: 19015020
[TBL] [Abstract][Full Text] [Related]
24. Review of the ethnobotany, chemistry, biological activity and safety of the botanical dietary supplement Morinda citrifolia (noni).
Pawlus AD; Kinghorn DA
J Pharm Pharmacol; 2007 Dec; 59(12):1587-609. PubMed ID: 18053321
[TBL] [Abstract][Full Text] [Related]
25. New constituents from noni (Morinda citrifolia) fruit juice.
Samoylenko V; Zhao J; Dunbar DC; Khan IA; Rushing JW; Muhammad I
J Agric Food Chem; 2006 Aug; 54(17):6398-402. PubMed ID: 16910736
[TBL] [Abstract][Full Text] [Related]
26. Dendritic cell activation by combined exposure to anti-CD40 plus interleukin (IL)-12 and IL-18 efficiently stimulates anti-tumor immunity.
Balkow S; Loser K; Krummen M; Higuchi T; Rothoeft T; Apelt J; Tuettenberg A; Weishaupt C; Beissert S; Grabbe S
Exp Dermatol; 2009 Jan; 18(1):78-87. PubMed ID: 19054060
[TBL] [Abstract][Full Text] [Related]
27. From Polynesian healers to health food stores: changing perspectives of Morinda citrifolia (Rubiaceae).
McClatchey W
Integr Cancer Ther; 2002 Jun; 1(2):110-20; discussion 120. PubMed ID: 14664736
[TBL] [Abstract][Full Text] [Related]
28. Enhancement of anti-tumor immunity by high levels of Th1 and Th17 with a combination of dendritic cell fusion hybrids and regulatory T cell depletion in pancreatic cancer.
Yamamoto M; Kamigaki T; Yamashita K; Hori Y; Hasegawa H; Kuroda D; Moriyama H; Nagata M; Ku Y; Kuroda Y
Oncol Rep; 2009 Aug; 22(2):337-43. PubMed ID: 19578774
[TBL] [Abstract][Full Text] [Related]
29. Chemotherapeutic potential of two gallic acid derivative compounds from leaves of Casearia sylvestris Sw (Flacourtiaceae).
Da Silva SL; Chaar Jda S; Yano T
Eur J Pharmacol; 2009 Apr; 608(1-3):76-83. PubMed ID: 19222998
[TBL] [Abstract][Full Text] [Related]
30. [Specific immune against pancreatic cancer induced by dendritic cells pulsed with mutant K-ras peptide].
Yang B; He Y; Sun DL; Zou Y; Qin XH; Huang BH
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1956-60. PubMed ID: 19062734
[TBL] [Abstract][Full Text] [Related]
31. Humoral immune responses inhibit the antitumor activities mediated by Salmonella enterica serovar choleraesuis.
Lee CH; Wu CL; Chen SH; Shiau AL
J Immunother; 2009 May; 32(4):376-88. PubMed ID: 19342967
[TBL] [Abstract][Full Text] [Related]
32. Endogenous IL-21 restricts CD8+ T cell expansion and is not required for tumor immunity.
Søndergaard H; Coquet JM; Uldrich AP; McLaughlin N; Godfrey DI; Sivakumar PV; Skak K; Smyth MJ
J Immunol; 2009 Dec; 183(11):7326-36. PubMed ID: 19915059
[TBL] [Abstract][Full Text] [Related]
33. Deficiency of GMDS leads to escape from NK cell-mediated tumor surveillance through modulation of TRAIL signaling.
Moriwaki K; Noda K; Furukawa Y; Ohshima K; Uchiyama A; Nakagawa T; Taniguchi N; Daigo Y; Nakamura Y; Hayashi N; Miyoshi E
Gastroenterology; 2009 Jul; 137(1):188-98, 198.e1-2. PubMed ID: 19361506
[TBL] [Abstract][Full Text] [Related]
34. Antifungal activity of Morinda citrifolia fruit extract against Candida albicans.
Jainkittivong A; Butsarakamruha T; Langlais RP
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Sep; 108(3):394-8. PubMed ID: 19716507
[TBL] [Abstract][Full Text] [Related]
35. Evidence of immune system melatonin production by two pineal melatonin deficient mice, C57BL/6 and Swiss strains.
Gómez-Corvera A; Cerrillo I; Molinero P; Naranjo MC; Lardone PJ; Sanchez-Hidalgo M; Carrascosa-Salmoral MP; Medrano-Campillo P; Guerrero JM; Rubio A
J Pineal Res; 2009 Aug; 47(1):15-22. PubMed ID: 19522737
[TBL] [Abstract][Full Text] [Related]
36. [Anti-tumor activity and mechanism with SSCE of Spatholobus suberctus].
Fu Q; Tang Y; Luo X; Yang G; He W; Wang X
Zhongguo Zhong Yao Za Zhi; 2009 Jun; 34(12):1570-3. PubMed ID: 19777849
[TBL] [Abstract][Full Text] [Related]
37. Inhibitory effects of Agaricus blazei extracts on human myeloid leukemia cells.
Kim CF; Jiang JJ; Leung KN; Fung KP; Lau CB
J Ethnopharmacol; 2009 Mar; 122(2):320-6. PubMed ID: 19162153
[TBL] [Abstract][Full Text] [Related]
38. Anti-cancer activity and mechanistic features of a NK cell activating molecule.
Kim HR; Lee KH; Park SJ; Kim SY; Yang YK; Tae J; Kim J
Cancer Immunol Immunother; 2009 Oct; 58(10):1691-700. PubMed ID: 19259669
[TBL] [Abstract][Full Text] [Related]
39. Site-specific anti-tumor immunity: differences in DC function, TGF-beta production and numbers of intratumoral Foxp3+ Treg.
Biollaz G; Bernasconi L; Cretton C; Püntener U; Frei K; Fontana A; Suter T
Eur J Immunol; 2009 May; 39(5):1323-33. PubMed ID: 19337997
[TBL] [Abstract][Full Text] [Related]
40. Immunostimulatory RNA oligonucleotides induce an effective antitumoral NK cell response through the TLR7.
Bourquin C; Schmidt L; Lanz AL; Storch B; Wurzenberger C; Anz D; Sandholzer N; Mocikat R; Berger M; Poeck H; Hartmann G; Hornung V; Endres S
J Immunol; 2009 Nov; 183(10):6078-86. PubMed ID: 19890064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
